Anti-LAMP2 抗体 [EPR19512] - Lysosome Marker
Anti-LAMP2 antibody [EPR19512] - Lysosome Marker
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- Lab Essentials
- 詳細を見る
Be the first to review this product! Submit a review
|
(16 Publications)
Rabbit Recombinant Monoclonal LAMP2 antibody. Lysosome marker. Suitable for WB, IHC-P and reacts with Human samples. Cited in 16 publications.
別名を表示する
CD107b, Lysosome-associated membrane glycoprotein 2, LAMP-2, Lysosome-associated membrane protein 2, CD107 antigen-like family member B, LGP-96, LAMP2
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LAMP2 antibody [EPR19512] - Lysosome Marker (AB199946)
Immunohistochemical analysis of paraffin-embedded Human kidney tissue labeling LAMP2 with ab199946 at 1/2000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution. Cytoplasm staining on Human kidney is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is ab97051 at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LAMP2 antibody [EPR19512] - Lysosome Marker (AB199946)
Immunohistochemical analysis of paraffin-embedded Human thyroid cancer tissue labeling LAMP2 with ab199946 at 1/2000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution. Cytoplasm staining on Human thyroid cancer is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is ab97051 at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- WB
Supplier Data
Western blot - Anti-LAMP2 antibody [EPR19512] - Lysosome Marker (AB199946)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : Lane 1 and 2 : 15 seconds; Lane 3,4 and 5 : 5 seconds.
The molecular weight observed is consistent with what has been described in the literature (PMID : 19828315) and lots of other products.
All lanes:
Western blot - Anti-LAMP2 antibody [EPR19512] - Lysosome Marker (ab199946) at 1/2000 dilution
Lane 1:
Human fetal liver lysate at 10 µg
Lane 2:
Human fetal heart lysate at 10 µg
Lane 3:
Human fetal kidney lysate at 10 µg
Lane 4:
Human fetal spleen lysate at 10 µg
Lane 5:
Human placenta lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG Peroxidase Conjugate, specific to the non-reduced form of IgG at 1/100000 dilution
Predicted band size: 45 kDa
Observed band size: 110-130 kDa
false
- WB
Unknown
Western blot - Anti-LAMP2 antibody [EPR19512] - Lysosome Marker (AB199946)
Lanes 1 - 4 : Merged signal (red and green). Green - ab199946 observed at 110 kDa. Red - loading control, ab8245 observed at 37 kDa.
ab199946 was shown to react with LAMP2 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab255402 (knockout cell lysate ab263861) was used. Wild-type and LAMP2 knockout samples were subjected to SDS-PAGE. ab199946 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 μg/ml and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-LAMP2 antibody [EPR19512] - Lysosome Marker (ab199946) at 1 µg/mL
Lane 1:
Wild-type HEK-293 cell lysate at 20 µg
Lane 2:
LAMP2 knockout HEK-293 cell lysate at 20 µg
Lane 3:
Wild-type HeLa cell lysate at 20 µg
Lane 4:
LAMP2 knockout HeLa cell lysate at 20 µg
Predicted band size: 45 kDa
Observed band size: 110 kDa,37 kDa
false
- WB
Lab
Western blot - Anti-LAMP2 antibody [EPR19512] - Lysosome Marker (AB199946)
Lanes 1 - 4 : Merged signal (red and green). Green - ab199946 observed at 45 kDa. Red - loading control, ab130007, observed at 130 kDa.
ab199946 was shown to recognize LAMP2 in wild-type HEK-293 cells as signal was lost at the expected MW in LAMP2 knockout cells. Additional cross-reactive bands were observed in the wild-type and knockout cells. Wild-type and LAMP2 knockout samples were subjected to SDS-PAGE. The membrane was blocked with 3% Milk. ab199946 and ab130007 (Mouse anti-Vinculin loading control) were incubated overnight at 4°C at 1/2000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-LAMP2 antibody [EPR19512] - Lysosome Marker (ab199946) at 1/2000 dilution
Lane 1:
Wild-type HEK-293 whole cell lysate at 20 µg
Lane 2:
LAMP2 knockout HEK-293 whole cell lysate at 20 µg
Lane 3:
HepG2 whole cell lysate at 20 µg
Lane 4:
THP1 whole cell lysate at 20 µg
Predicted band size: 45 kDa
false
- WB
Supplier Data
Western blot - Anti-LAMP2 antibody [EPR19512] - Lysosome Marker (AB199946)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : Lane 1,2 and 3 : 1 second; Lane 4 : 5 seconds.
The molecular weight observed is consistent with what has been described in the literature (PMID : 19828315) and lots of other products.
All lanes:
Western blot - Anti-LAMP2 antibody [EPR19512] - Lysosome Marker (ab199946) at 1/2000 dilution
Lane 1:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
THP-1 (Human monocytic leukemia cell line) whole cell lysate at 20 µg
Lane 3:
JAR (Human placenta choriocarcinoma cell line) whole cell lysate at 20 µg
Lane 4:
Jurkat (Human T cell leukemia cell line from peripheral blood) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 45 kDa
Observed band size: 110-130 kDa
false
関連する標識済み抗体及び組成の異なる製品 (1)
-
Anti-LAMP2 antibody [EPR19512] - BSA and Azide free
Reactivity data
製品の詳細
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
LAMP2 is essential for the normal fusion of lysosomes with autophagosomes. This process ensures the recycling of cellular components and maintenance of cellular homeostasis. LAMP2 acts in conjunction with other members of the lysosome-associated membrane protein family LAMP1 and LAMP3 forming part of a larger complex. This interaction is fundamental in managing the degradation pathways within the cell supporting processes such as lipid metabolism and protein turnover.
Pathways
The activity of LAMP2 is critical in the autophagic and degradation pathways within the cell. It particularly interacts in the autophagy-lysosome pathway where it aids the clearance of damaged organelles and protein aggregates. LAMP2 interaction with proteins such as the autophagy-related protein LC3 helps this degradation process. Additionally LAMP2 plays a role in endocytic pathways linking it to proteins involved in vesicle trafficking and membrane fusion.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (16)
Recent publications for all applications. Explore the full list and refine your search
Molecular neurodegeneration 20:32 PubMed40082954
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature cell biology 27:438-448 PubMed39984653
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 301:108257 PubMed39909373
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of biological sciences 20:4382-4406 PubMed39247814
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of nanobiotechnology 22:298 PubMed38811968
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 14:451 PubMed37474520
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine (Cambridge, Mass.) 29:96 PubMed37438701
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 83:2524-2539.e7 PubMed37390818
2023
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 42:e112387 PubMed36872914
2023
Applications
Unspecified application
Species
Unspecified reactive species
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 56:e12279 PubMed36722658
2023
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com